(Q44444411)

3 December 2017

Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies (English)

1 reference

3 December 2017

Helicobacter pylori eradication and gastric ulcer healing — comparison of three pantoprazole‐based triple therapies (English)

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

3 January 2024

1 reference

1 reference

BYK Advanced Gastric Ulcer Study Group

9

1 reference

3 December 2017

P. Malfertheiner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752349

3 January 2024

T. Kirchner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752349

3 January 2024

M. Kist

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752349

3 January 2024

A. Leodolter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752349

3 January 2024

U. Peitz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752349

3 January 2024

S. Strobel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752349

3 January 2024

M. Bohuschke

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752349

3 January 2024

G. Gatz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752349

3 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

3 December 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2036.2003.01560.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12752349

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2036.2003.01560.x

3 January 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2036.2003.01560.x

3 January 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

Alimentary Pharmacology & Therapeutics

3 January 2024

published in

1 reference

3 December 2017

17

1 reference

3 December 2017

1125-1135

1 reference

3 December 2017

9

1 reference

Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection

3 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01560.X

Antral atrophy, Helicobacter pylori colonization, and gastric pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01560.X

Canadian Helicobacter pylori consensus conference. Canadian Association of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01560.X

Eradication of Helicobacter pylori: an objective assessment of current therapies

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer

3 January 2024

2

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers

3 January 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients

3 January 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

3 January 2024

6

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

Cure of Helicobacter pylori-associated ulcer disease through eradication

3 January 2024

7

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

Patterns of inflammation linked to ulcer disease

3 January 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis

3 January 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

Differing patterns of Helicobacter pylori gastritis in patients with duodenal, prepyloric, and gastric ulcer disease.

3 January 2024

13

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group

3 January 2024

14

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

3 January 2024

16

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

The Maastricht recommendations and their impact on general practice

3 January 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994

3 January 2024

18

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy

3 January 2024

21

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting

3 January 2024

22

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study

3 January 2024

24

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies

3 January 2024

25

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

Metronidazole activation is mutagenic and causes DNA fragmentation in Helicobacter pylori and in Escherichia coli containing a cloned H. pylori RdxA(+) (Nitroreductase) gene

3 January 2024

27

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis

3 January 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01560.X

3 January 2024

Identifiers

1 reference

3 December 2017

1 reference